Tuesday, April 16, 2024 8:26:36 PM
Mr. Meneghello and Mr. Travagli shall be paid the monthly salary by way of the quarterly issuance of unregistered restricted shares of common stock of ATMH (the “Shares”), valued at a 30% discount to the market price of the Shares based on the Market price on the OTCQB Market, on the last day of each quarter, until the Company, at its sole discretion, is in a position to pay the Employee in cash.
Accumulated deficit (7,953,349)
TOTAL LIABILITIES 1,801,674
Revenue $ 1,795,519
Cost of revenue $-1,780,948 -
Gross profit 14,571
Net loss $ (11,016)
The Company has an accumulated deficit of $7,953,349 as of April 30, 2023 and has incurred operating losses to date. The Company expects that while it is restructuring and completing certain identified acquisition targets it will continue to incur operating losses. The Company has been funded to date by current management and expects this funding to continue until such time as initial revenues from currently planned operations commence. There can be no assurance that the Company will continue to receive funding from management or that it will be able to raise sufficient funds from the sale of securities or debt, or that the funding it does receive will be sufficient to pay for its operations.
Management’s plans for the continuation of the Company as a going concern include the identification and completion of acquisitions, the financing of the Company’s operations through issuance of its common stock and shareholder advances. Its continuation as a going concern is dependent upon its ability to, to obtain additional financing as may
be required to meet its obligations on a timely basis, to identify, acquire and develop a commercially viable business and ultimately to establish profitable operations.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM